annual working capital:
$302.21M+$61.95M(+25.79%)Summary
- As of today (August 22, 2025), ELVN annual working capital is $302.21 million, with the most recent change of +$61.95 million (+25.79%) on December 31, 2024.
- During the last 3 years, ELVN annual working capital has risen by +$197.29 million (+188.05%).
- ELVN annual working capital is now at all-time high.
Performance
ELVN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$480.41M+$200.06M(+71.36%)Summary
- As of today (August 22, 2025), ELVN quarterly working capital is $480.41 million, with the most recent change of +$200.06 million (+71.36%) on June 30, 2025.
- Over the past year, ELVN quarterly working capital has increased by +$184.39 million (+62.29%).
- ELVN quarterly working capital is now at all-time high.
Performance
ELVN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
ELVN Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +25.8% | +62.3% |
3 y3 years | +188.1% | +688.1% |
5 y5 years | +1043.6% | +354.3% |
ELVN Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +244.2% | at high | +738.6% |
5 y | 5-year | at high | +1043.6% | at high | +738.6% |
alltime | all time | at high | +5045.8% | at high | +738.6% |
ELVN Working capital History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $480.41M(+71.4%) |
Mar 2025 | - | $280.35M(-7.2%) |
Dec 2024 | $302.21M(+25.8%) | $302.21M(+7.9%) |
Sep 2024 | - | $279.97M(-5.4%) |
Jun 2024 | - | $296.02M(-5.2%) |
Mar 2024 | - | $312.17M(+29.9%) |
Dec 2023 | $240.26M(+173.6%) | $240.26M(-6.3%) |
Sep 2023 | - | $256.53M(-6.4%) |
Jun 2023 | - | $274.03M(-4.5%) |
Mar 2023 | - | $287.06M(+226.9%) |
Dec 2022 | $87.81M | $87.81M(+53.3%) |
Sep 2022 | - | $57.29M(-6.0%) |
Jun 2022 | - | $60.95M(-14.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $71.31M(-16.6%) |
Dec 2021 | $104.92M(+24.7%) | - |
Dec 2021 | - | $85.49M(-13.5%) |
Sep 2021 | - | $98.81M(+53.5%) |
Jun 2021 | - | $64.38M(-14.0%) |
Mar 2021 | - | $74.86M(-11.1%) |
Dec 2020 | $84.16M(+218.5%) | $84.16M(-10.9%) |
Sep 2020 | - | $94.40M(-10.7%) |
Jun 2020 | - | $105.75M(+0.8%) |
Mar 2020 | - | $104.87M |
Dec 2019 | $26.43M(+350.0%) | - |
Dec 2018 | $5.87M(-37.5%) | - |
Dec 2017 | $9.40M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual working capital?
- What is the all time high annual working capital for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual working capital year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly working capital?
- What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?
What is Enliven Therapeutics, Inc. annual working capital?
The current annual working capital of ELVN is $302.21M
What is the all time high annual working capital for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual working capital is $302.21M
What is Enliven Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, ELVN annual working capital has changed by +$61.95M (+25.79%)
What is Enliven Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of ELVN is $480.41M
What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly working capital is $480.41M
What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, ELVN quarterly working capital has changed by +$184.39M (+62.29%)